White House pushes US drug prices with tariff threatening in Europe

Unlock White House Clock Bulletin Free

Your guide on what Trump’s second term for Washington, Business and the World means

President Donald Trump has pledged to force European countries to pay the highest drug prices, while healthcare companies have reduced the prices of North -American consumers to 80 percent.

Speaking on Monday at the White House, Trump said that his administration would punish countries that refuse to “equal” their Medication prices with USA Or that the pharmaceutical companies “extort” to reduce their positions.

The threat, which included the imposition of commercial sanctions on non-cooperative nations, opens a new conflict with American commercial partners after Trump’s release rates imposed worldwide last month.

“Let’s tell those countries, such as those represented by the European Union, that the game is over, sorry,, Trump he said. “And if they want to be nice, they will no longer have to sell cars in the United States.”

Trump on Monday signed an executive order that the White House said “would communicate the price goals for pharmaceutical manufacturers” and cut “intermediaries” by allowing patients to buy directly from medicine manufacturers directly.

This proposed policy focused on the intermediaries affected the actions of CIGNA and CVS, two of the largest pharmacy benefits managers who negotiate prices between manufacturers and health insurance companies.

CIGNA and CVS actions dropped by 6 percent and 4.5 percent respectively in the afternoon negotiation despite a wide manifestation of the stock market. “Swan faces the greatest risk of disadvantage if the United States government begins to negotiate drug prices,” Morningsar said in a Monday afternoon report.

The president wants to reduce US medicine prices at the lowest price available worldwide. North -Americans have historically paid much higher Drug prices than their colleagues in other industrialized countries.

Trump’s directive could harm North -American pharmaceutical companies, which have taken years to preserve the North -Americans Price System. During the first term, Trump proposed drug controls, but that was defeated in court. Democrats have also tried to reinstate the cost of drugs. Trump’s latest proposal faces a similar struggle, the analysts said Monday.

Trump said the pricing of medication in the United States meant that the North -Americans paid an undue share pharmacist Business research and development costs.

He said that the United States Commercial Representative and Department of Commerce would be aimed at sounding nations that “extort pharmaceutical companies by blocking their products unless they accept.”

“This means that North -Americans effectively subsidized socialist health systems in Germany, in all parts of the EU, were the hardest of all. They were unpleasant,” said Trump. “Basically what we are doing is equal.”

Unlike Europe, U.S. government insurance programs cannot negotiate certain drug prices with pharmaceutical companies. The inflation reduction law of former President Joe Biden allowed Medicare, a public insurance program for the elderly, to do it for the first time for some medicines.

The United States paid approximately 3.2 times for brand drugs than other countries developed by 2022, according to Rand Healthcare’s research for the country’s Health and Health Department.

Trump’s announcement has begun a struggle with the pharmaceutical industry. The Biotechnology Innovation Organization, a United States Lobby Group, said that the President’s plan was similar to “importing socialized medicine”.

“Patients and families are not a negotiation chip in a trade war, but it is exactly how they are treated,” he said on Monday.